The COVID-19 Pandemic – Webinars and Online Events

Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.

In this webinar, we will explore the common challenges encountered by developers and manufacturers when developing PCR tests, and how these challenges can be overcome with the right technologies.

To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.

Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.

Analysis of SARS-CoV-2-specific T cells is important in understanding their role during acute disease and in long-term protection. Find out about some of the tools used in T-cell research and the promise they show as a cell therapy for COVID-19.

These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.

Recent technical advances allow investigators to analyze clinical samples with robust high-throughput proteomic workflows, creating an opportunity to analyze large numbers of patient samples during the COVID-19 pandemic.

As we all know, current global research efforts are focused on understanding the SARS-CoV-2 virus. Developing vaccines and therapies to combat the virus has become a priority, laboratories are addressing research questions at key stages in viral infectivity workflows.

This webinar will provide a behind the scenes vignette of how to build leadership in the vaccine sciences, an overview of the vaccine development process and highlight a case study of how a COVID-19 vaccine, suitable for global access, was developed and is currently advancing towards achieving emergency use authorization for distribution and global access.

Vaccination has proven to be the most successful form of disease prevention available today. However, infectious diseases still account for large numbers of the yearly reported casualties, especially in developing countries.